BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5172361)

  • 21. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
    [No Abstract]   [Full Text] [Related]  

  • 22. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of B.663 in human leprosy.
    Atkinson AJ; Sheagren JN; Rubio JB; Knight V
    Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
    Waters MF
    Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
    Morgan J
    Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clofazimine and the eye].
    Negrel AD; Baquillon G; de La Panouse A; Ducam M; Bagadec R; Chovet M
    Acta Leprol; 1981; (84):31-7. PubMed ID: 6797221
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of neuritis in leprosy.
    Pfaltzgraff RE
    Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily).
    Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P
    Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of experimental chemotherapy of leprosy.
    Banerjee DK
    Lepr India; 1976 Oct; 48(4 Suppl):686-9. PubMed ID: 800233
    [No Abstract]   [Full Text] [Related]  

  • 33. G 30 320 or B 663--lampren (Geigy).
    Waters MF
    Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of three-year multidrug therapy in multibacillary leprosy patients.
    Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
    [No Abstract]   [Full Text] [Related]  

  • 36. Leprosy.
    Hendrick SS; Wilkin JK
    Am Fam Physician; 1982 Nov; 26(5):161-6. PubMed ID: 7148625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Story behind the clinical trial of B.663 in leprosy.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
    Pearson JM; Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
    [No Abstract]   [Full Text] [Related]  

  • 39. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute abdomen in a patient treated with lamprene.
    Jagadeesan K; Visweswaran MK; Iyer KH
    Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.